This is the authors' abstract. We don't add key points for this paper.
Our results reveal a cis-activating mechanism harnessing host ELF4 and HBV integrated at the TERT promoter and uncover how TERT HBV-integrated HCCs may achieve TERT activation in hepatocarcinogenesis.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sze et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: